Department of Neurology
Valens, Canton of St. Gallen, 7317, Switzerland
NCT Number: NCT04108741
Gait disorder is a disabling symptom in Parkinson's disease (PD) affecting all patients during the course. Three methods of treadmill training (TT) will be compared to assess additional augmented reality (AR), or additional dual task (DT). AR TT, DT TT, and TT alone applied over 3 weeks at each day will be compared for their impact on falls, walking, freezing and attention for 3 months in a double blinded randomized controlled trial during regular neurorehabilitation.
Looking for future studies?
Notify Me35 year–99 year
All sexes
Interventional
Not applicable
Valens, Canton of St. Gallen, 7317, Switzerland
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
PD Patients will be randomized to treadmill training with augmented reality or to treadmill training with random number generation or to treadmill training for 3 weeks at 5 days a week for 30 minutes.
Time frame: 3 months before study to 3 months following the study
group difference of the difference in falls
Time frame: before and after the training period of 3 weeks
Freezing of Gait (FOG) Questionnaire
Time frame: before and after the training period of 3 weeks and after 3 months
for one week
Klinik Valens
Other
Augmented Reality Treadmill Training in Patients With Parkinson's Disease: a Randomized Controlled Study
Acronym: Falls_in_PD
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07399613
Accidental Falls, Basal Ganglia Diseases
Glendale, Arizona, United States
View Trial DetailsNCT07058285
Basal Ganglia Diseases, Brain Diseases
Kiel, Germany
View Trial DetailsNCT05940077
Basal Ganglia Diseases, Behavior
Pocatello, Idaho, United States
View Trial DetailsNCT04622657
Balance; Distorted, Basal Ganglia Diseases
Kirikkale, Turkey (Türkiye)
View Trial Details